Sotyktu Tablet, Film Coated
Product Images NDC 0003-0895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sotyktu (NDC 0003-0895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure (Chem Structure)

FDA Label Image

Deucravacitinib-principal-display-panel-label.jpg (Deucravacitinib Principal Display Panel Label)

Deucravacitinib-principal-display-panel-label.jpg (Deucravacitinib Principal Display Panel Label)
The text is a list of items including "WCOmT 30 Tables" and "SOTYKTUS" and mentions "deucravacitinib" tablets for oral use by Bristol Myers. No additional information or context is available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.